411646

Role of Curcumin and Fenofibrate on Cardiovascular Events in Type 2 Diabetes Mellitus.

Article

Last updated: 09 Apr 2025

Subjects

-

Tags

Clinical pharmacy and therapeutics.

Abstract

Background and aim
Type 2 diabetes mellitus is associated with cardiovascular complications that account for a high percentage of mortality and increase the clinical burden on the healthcare system. Herbal products like curcumin and chemical drugs like fenofibrate were found to be effective in decreasing complications associated with heart in type 2 diabetes. The aim of this study is to evaluate the role of curcumin and fenofibrate on cardiovascular complications in type 2 diabetes in a minireview.
Methods
We reviewed the online databases PubMed, Science Direct, and Google Scholar for articles discussing the impact of curcumin or fenofibrate in improving lipid profile in patients with type 2 diabetes.
Results
The prior studies demonstrated the impact of consuming curcumin or fenofibrate to improve the lipid profile in people with type 2 diabetes. Triglycerides (TG), low-density lipoprotein (LDL), and total cholesterol (TC) were reduced with either curcumin or fenofibrate. In contrast, high-density lipoprotein (HDL) levels were increased.
Conclusions
Curcumin or fenofibrate consumption in patients with type 2 diabetes enhances lipid profile, hence decreasing insulin resistance and reducing cardiovascular complications.

DOI

10.21608/jampr.2025.354114.1086

Keywords

Type 2 Diabetes, Curcumin, fenofibrate, Lipid profile, Cardiovascular complications

Authors

First Name

Rehab

Last Name

Werida

MiddleName

H.

Affiliation

Associate Professor of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhur University, Damanhour 22514, Egypt.

Email

rehabwrieda@pharm.dmu.edu.eg

City

Damanhour

Orcid

0000-0002-5983-3993

First Name

Eman

Last Name

Nada

MiddleName

M.

Affiliation

Master candidate, Ministry of Health and Population, Damanhour City, Egypt.

Email

eman.nada@pharm.dmu.edu.eg

City

Damanhour

Orcid

0000-0002-0765-5208

First Name

Nashwa

Last Name

El-Gharbawy

MiddleName

M.

Affiliation

Associate Professor of Internal Medicine-Diabetes &Endocrinology, Faculty of Medicine, Tanta University, Tanta, Egypt.

Email

nashwa.elgharbawy@med.tanta.edu.eg

City

Tanta

Orcid

0000-0002-2551-0731

First Name

Haidy

Last Name

Abass

MiddleName

A.

Affiliation

Professor of Pharmaceutics, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt.

Email

haidy.abass@pharm.dmu.edu.eg

City

Damanhour

Orcid

0000-0003-4243-1442

Volume

6

Article Issue

1

Related Issue

54787

Issue Date

2025-03-01

Receive Date

2025-01-24

Publish Date

2025-03-01

Page Start

48

Page End

52

Online ISSN

2636-4158

Link

https://jampr.journals.ekb.eg/article_411646.html

Detail API

http://journals.ekb.eg?_action=service&article_code=411646

Order

411,646

Type

Mini review

Type Code

2,812

Publication Type

Journal

Publication Title

Journal of Advanced Medical and Pharmaceutical Research

Publication Link

https://jampr.journals.ekb.eg/

MainTitle

Role of Curcumin and Fenofibrate on Cardiovascular Events in Type 2 Diabetes Mellitus.

Details

Type

Article

Created At

09 Apr 2025